According to Paratek Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ0.85. In 2022 the company made an earnings per share (EPS) of -ยฃ0.91 an increase over its 2021 EPS that were of -ยฃ0.94.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ0.92 | 1% |
2022 | -ยฃ0.91 | -3.28% |
2021 | -ยฃ0.94 | -44.29% |
2020 | -ยฃ1.69 | -44.27% |
2019 | -ยฃ3.03 | 10.08% |
2018 | -ยฃ2.76 | 6.57% |
2017 | -ยฃ2.59 | -40.5% |
2016 | -ยฃ4.35 | 33.1% |
2015 | -ยฃ3.27 | -55.46% |
2014 | -ยฃ7.33 | -45.8% |
2013 | -ยฃ13.53 | 92.11% |
2012 | -ยฃ7.04 | 162.07% |
2011 | -ยฃ2.69 | -57.97% |
2010 | -ยฃ6.39 | -64.06% |
2009 | -ยฃ17.79 | -49.99% |
2008 | -ยฃ35.57 | -44.5% |
2007 | -ยฃ64.09 | -76.9% |
2006 | -ยฃ277.48 | -64.83% |
2005 | -ยฃ788.91 | 2.84% |
2004 | -ยฃ767.14 |